• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
  • Aeterna Zentaris Announces Plans to Pursue FDA Registration of Macrilen™ americanpharmaceuticalreview
    February 15, 2017
    Eli Lilly and Company and Incyte Corporation announced that the European Commission has granted marketing authorization for Olumiant® (baricitinib) 4 mg and 2 mg film-coated tablets in Europe for the treatment of moderate-to-severe active rheumatoid arthr

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service